Last updated on November 2018

This Study Tests Whether BI 409306 Prevents Patients With a Specific Type of Mental Illness (Attenuated Psychosis Syndrome) From Becoming Worse. This Study Looks at How Well Patients Tolerate the Medicine and How Effective it is Over 1 Year

Brief description of study

To investigate the efficacy, safety and tolerability of BI 409306 once daily compared to placebo given for 52 weeks to subjects with attenuated psychosis syndrome.

Clinical Study Identifier: NCT03230097

Contact Investigators or Research Sites near you

Start Over

Pavan Mallikarjun

The Barberry National Centre for Mental Health
Birmingham, United Kingdom
  Connect »